Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Anyone want to guess at RBC's new target price?

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Jan 12, 2021 3:18pm

104 Views

Post# 32278065

RE:RE:RE:RE:RE:RE:RE:Anyone want to guess at RBC's new target price?

That is kind of you to say but I have no interest in serving on the board. But I am perplexed that the board would have agreed to go ahead with such an awful deal.

Jasonthehumble wrote: How about we reduce compensation to board members to save on cost? How about we make SPEO, a board member and give him no compensation. At least he would do what is best for the company and be more transparent.

scarlet1967 wrote: If you can get 30% plus some 30% shareholders on this board even the total will be reduced due to dilution as well engaged shareholders we should be able to make our voice heard, nobody here wants to wait another minute not to mention months or years of being neglected as a royal shareholder.

SPCEO1 wrote: We are not 30% holders and we lost some accounts this past year which slightly reduced our holdings from the 6.8 million shares we held at the end of 2019. But I know I could probably account for 20% with about 5 or 6 phone calls and getting to 30%, at least pre-offering, would not require a ton of work.

Wino115 wrote: At a minimum, they should have brought you in under the NDA and offered you the equivalent ownership to avoid dilution. Not even giving you an NDA is a snub as a 30% holder in my book.

Wino115 wrote: SPCEO, you think your avowed disinterest in being "activist" was something they took advantage of -- completely ignoring your logic and your past discussions and warnings? They may have known you wouldn't really do anything from past behavior. It's certainly a smack in the face from them though. Maybe it will be time for us to be more forceful at the meeting this year -- especially on comp and pay plans. I'm good with the new board members coming in.

Jasonthehumble wrote: Since the majority of us are retail investors, we should all ban together and vote against everything the board and management recommends the next quarterly earnings. They need to see who really is in charge and my hope is that they see how disgruntled we all are.

SPCEO1 wrote: I will guess $1.65.

Of course it will also be interesting to see what changes, if any, Mackie, Canaccord and NBF make too.